Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QUE

Spinal Muscular Atrophy Newborn Screening Test System

A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.

Product / regulatory recordCompanyPathwayDecision dateSource
Revvity, Inc.510(k) clearanceSep 30, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories